UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 270

Sortiert nach

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's & dementia, 2011-05, Vol.7 (3), p.270-279

2011

Volltextzugriff (PDF)

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Lancet neurology, 2007-08, Vol.6 (8), p.734-746

2007

Volltextzugriff (PDF)

CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease

Nature reviews. Neurology, 2022-07, Vol.18 (7), p.379

2022

Volltextzugriff (PDF)

BIOMARKERS ARE USEFUL IN TERTIARY CARE CLINICAL DECISION-MAKING

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P370-P370

Feldman, Howard H

2016

Volltextzugriff (PDF)

Mild Cognitive Impairment

The American journal of geriatric psychiatry, 2005-08, Vol.13 (8), p.645-655

2005

Volltextzugriff (PDF)

Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials

International journal of statistics in medical research, 2023-02, Vol.12, p.90-96

2023

Volltextzugriff (PDF)

Alzheimer's disease research and development: a call for a new research roadmap

Annals of the New York Academy of Sciences, 2014-04, Vol.1313 (1), p.1-16

2014

Volltextzugriff (PDF)

OBSESSIVE COMPULSIVE SYMPTOMS BEFORE FRONTOTEMPORAL DEMENTIA: A REVIEW OF IMAGING CASE SERIES

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1067-P1067

2016

Volltextzugriff (PDF)

New lexicon and criteria for the diagnosis of Alzheimer's disease – Authors' reply

Lancet neurology, 2011-04, Vol.10 (4), p.300-301

2011

Volltextzugriff (PDF)

ANTEMORTEM OCCIPITAL PERIVENTRICULAR WHITE MATTER HYPERINTENSITIES PREDICT CEREBRAL AMYLOID PATHOLOGY AT AUTOPSY

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P408-P409

2016

Volltextzugriff (PDF)

EVALUATION OF CIRCADIAN RHYTHMS AND SLEEP IN THE APP/PS1 MOUSE MODEL OF ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1031-P1032

2016

Volltextzugriff (PDF)

PHASE 3 TRIAL OF THE TAU AGGREGATION INHIBITOR LEUCO-METHYLTHIONINIUM-BIS (HYDROMETHANESULFONATE) (LMTM) IN MILD TO MODERATE ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P351-P352

2016

Volltextzugriff (PDF)

Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

Pharmacogenetics and genomics, 2008-04, Vol.18 (4), p.289-298

2008

Volltextzugriff (PDF)

F5‐03‐02: Biomarkers are Useful in Tertiary Care Clinical Decision‐Making

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_7), p.P370-P370

Feldman, Howard H.

2016

Volltextzugriff (PDF)

Virtual Design of the Brain Health Support Program and CAN‐THUMBS UP

Alzheimer's & dementia, 2023-12, Vol.19 (S23), p.n/a

2023

Volltextzugriff (PDF)

The relationship between rater experience and performance on certification exercises and study subject ratings in an Alzheimer trial

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S486-S486

2010

Volltextzugriff (PDF)

ADAS-Cog central monitoring and intervention with raters: A critical extension and integral component of Alzheimer trials rater training programs

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S483-S483

2010

Volltextzugriff (PDF)

Cognitive and clinical outcomes in a pilot study using a handheld computer game for cognitive training of patients with Mild Cognitive Impairment (MCI)

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P411-P411

2009

Volltextzugriff (PDF)

Assessing outcome measures for prodromal AD clinical trials: A retrospective analysis from the ADNI database

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P363-P363

2009

Volltextzugriff (PDF)

Evoke et evoke + : design de deux études de phase 3 randomisées en double aveugle, contrôlées par placebo, évaluant les effets neuroprotecteurs du semaglutide dans la maladie d’Alzheimer au stade débutant

Revue neurologique, 2024-04, Vol.180, p.S169-S170

2024

Volltextzugriff (PDF)

Alzheimer’s Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned?

Alzheimer's & dementia, 2006-07, Vol.2 (3), p.220-233

2006

Volltextzugriff (PDF)

Virtual Cognitive Testing‐ Neuropsychology, MyCogHealth and Cogniciti

Alzheimer's & dementia, 2023-12, Vol.19 (S23), p.n/a

2023

Volltextzugriff (PDF)

Generation and characterization of a mouse model of progranulin deficiency

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S65-S65

2010

Volltextzugriff (PDF)

Cross-sectional validation of a new instrument for the measurement of treatment response: The Clinical Meaningfulness in Alzheimer Disease Treatment (CLIMAT) scale

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P184-P184

2009

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(249)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(83)
Science & Technology
(57)
Male
(51)
Female
(50)
Alzheimer's Disease
(46)
Science & Technology - Other Topics
(46)
Multidisciplinary Sciences
(45)
Aged
(39)
Neurology
(39)
Middle Aged
(27)
Neurodegenerative Diseases
(26)
Neuroimaging
(24)
Aged, 80 And Over
(21)
Biological And Medical Sciences
(20)
Magnetic Resonance Imaging
(20)
Medical Imaging
(20)
Cognitive Ability
(19)
Biomarkers
(18)
Adult
(17)
Brain
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)

CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease

BIOMARKERS ARE USEFUL IN TERTIARY CARE CLINICAL DECISION-MAKING

Mild Cognitive Impairment

Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials

Alzheimer's disease research and development: a call for a new research roadmap

OBSESSIVE COMPULSIVE SYMPTOMS BEFORE FRONTOTEMPORAL DEMENTIA: A REVIEW OF IMAGING CASE SERIES

New lexicon and criteria for the diagnosis of Alzheimer's disease – Authors' reply

ANTEMORTEM OCCIPITAL PERIVENTRICULAR WHITE MATTER HYPERINTENSITIES PREDICT CEREBRAL AMYLOID PATHOLOGY AT AUTOPSY

EVALUATION OF CIRCADIAN RHYTHMS AND SLEEP IN THE APP/PS1 MOUSE MODEL OF ALZHEIMER’S DISEASE

PHASE 3 TRIAL OF THE TAU AGGREGATION INHIBITOR LEUCO-METHYLTHIONINIUM-BIS (HYDROMETHANESULFONATE) (LMTM) IN MILD TO MODERATE ALZHEIMER'S DISEASE

Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

F5‐03‐02: Biomarkers are Useful in Tertiary Care Clinical Decision‐Making

Virtual Design of the Brain Health Support Program and CAN‐THUMBS UP

The relationship between rater experience and performance on certification exercises and study subject ratings in an Alzheimer trial

ADAS-Cog central monitoring and intervention with raters: A critical extension and integral component of Alzheimer trials rater training programs

Cognitive and clinical outcomes in a pilot study using a handheld computer game for cognitive training of patients with Mild Cognitive Impairment (MCI)

Assessing outcome measures for prodromal AD clinical trials: A retrospective analysis from the ADNI database

Evoke et evoke + : design de deux études de phase 3 randomisées en double aveugle, contrôlées par placebo, évaluant les effets neuroprotecteurs du semaglutide dans la maladie d’Alzheimer au stade débutant

Alzheimer’s Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned?

Virtual Cognitive Testing‐ Neuropsychology, MyCogHealth and Cogniciti

Generation and characterization of a mouse model of progranulin deficiency

Cross-sectional validation of a new instrument for the measurement of treatment response: The Clinical Meaningfulness in Alzheimer Disease Treatment (CLIMAT) scale

Aktive Filter

Suchergebnisse filtern